U.S. Dialysis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032
U.S. Dialysis Market exhibited USD 28.8 billion in 2023 and will expand to a 5.5% CAGR from 2024 to 2032, spurred by the rising number of end-stage renal disease (ESRD) patients and the increasing incidence of diabetes. As diabetes becomes more prevalent, it heightens the risk of developing kidney-related complications, leading to a greater demand for dialysis services. Also, the aging population contributes to the growing prevalence of ESRD, further stressing healthcare systems. This surge in patient numbers necessitates advancements in dialysis technology and treatment options, ultimately expanding the market and improving patient outcomes.
The U.S. dialysis industry is fragmented based on type, product & services, end-use, and region. The hemodialysis segment upheld USD 25.4 billion in 2023 due to its widespread adoption as a primary treatment for end-stage renal disease (ESRD). Hemodialysis offers effective filtration of blood, making it a preferred choice for many patients requiring regular treatment. The availability of advanced hemodialysis machines and improved access to outpatient facilities further enhance its appeal.
Besides, as awareness of kidney health increases and more patients are diagnosed with ESRD, the demand for hemodialysis services is likely to continue growing, solidifying its market dominance. The service segment garnered 78.3% share in 2023, driven by the increasing demand for comprehensive care and support for patients with end-stage renal disease (ESRD). This segment encompasses various services, including dialysis treatment, patient education, and care coordination, which are essential for ensuring optimal patient outcomes. As healthcare providers focus on enhancing the patient experience and improving accessibility to dialysis services, the emphasis on service-oriented solutions will grow.
This trend positions the service segment as a vital component of the overall dialysis market. The South Atlantic dialysis industry secured USD 6.5 billion in 2023 and will grow at a 5.1% CAGR through 2032, driven by a growing population and increasing prevalence of chronic kidney diseases. The area has a high concentration of healthcare facilities specializing in renal care, making dialysis services more accessible to patients. Moreover, rising awareness of kidney health and advancements in dialysis technology are further fueling demand.As the region continues to prioritize healthcare infrastructure and patient support, the South Atlantic will stand as a vital contributor to the overall dialysis market.
The U.S. dialysis industry is fragmented based on type, product & services, end-use, and region. The hemodialysis segment upheld USD 25.4 billion in 2023 due to its widespread adoption as a primary treatment for end-stage renal disease (ESRD). Hemodialysis offers effective filtration of blood, making it a preferred choice for many patients requiring regular treatment. The availability of advanced hemodialysis machines and improved access to outpatient facilities further enhance its appeal.
Besides, as awareness of kidney health increases and more patients are diagnosed with ESRD, the demand for hemodialysis services is likely to continue growing, solidifying its market dominance. The service segment garnered 78.3% share in 2023, driven by the increasing demand for comprehensive care and support for patients with end-stage renal disease (ESRD). This segment encompasses various services, including dialysis treatment, patient education, and care coordination, which are essential for ensuring optimal patient outcomes. As healthcare providers focus on enhancing the patient experience and improving accessibility to dialysis services, the emphasis on service-oriented solutions will grow.
This trend positions the service segment as a vital component of the overall dialysis market. The South Atlantic dialysis industry secured USD 6.5 billion in 2023 and will grow at a 5.1% CAGR through 2032, driven by a growing population and increasing prevalence of chronic kidney diseases. The area has a high concentration of healthcare facilities specializing in renal care, making dialysis services more accessible to patients. Moreover, rising awareness of kidney health and advancements in dialysis technology are further fueling demand.As the region continues to prioritize healthcare infrastructure and patient support, the South Atlantic will stand as a vital contributor to the overall dialysis market.
Report Content
CHAPTER 1 METHODOLOGY & SCOPE
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising number of end - stage renal diseases (ESRD) patients
3.2.1.2 Increasing incidence of diabetes
3.2.1.3 Shortage of donor kidneys
3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
3.2.1.5 Growing R&D investments
3.2.2 Industry pitfalls & challenges
3.2.2.1 Product recalls
3.2.2.2 Complications in the treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Value chain analysis
3.7 Future market trends
3.8 Technology landscape
3.9 Porter’s analysis
3.10 PESTEL analysis
CHAPTER 4 COMPETITIVE LANDSCAPE, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY TYPE, 2021 – 2032 ($ MN)
5.1 Key trends
5.2 Hemodialysis
5.3 Peritoneal dialysis
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY PRODUCT AND SERVICES, 2021 – 2032 ($ MN)
6.1 Key trends
6.2 Services
6.2.1 Chronic dialysis
6.2.2 Acute dialysis
6.3 Consumables
6.3.1 Dialyzers
6.3.2 Catheters
6.3.3 Access products
6.3.4 Concentrates
6.3.5 Other consumables
6.4 Equipment
6.4.1 Dialysis machines
6.4.2 Water treatment systems
6.4.3 Other equipment
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY END-USE, 2021 – 2032 ($ MN)
7.1 Key trends
7.2 In-center dialysis
7.3 Home dialysis
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY ZONE, 2021 – 2032 ($ MN)
8.1 Key trends
8.2 East North Central
8.3 West South Central
8.4 South Atlantic
8.5 North East
8.6 East South Central
8.7 West North Central
8.8 Pacific Central
8.9 Mountain States
CHAPTER 9 COMPANY PROFILES
9.1 Asahi Kasei Corporation
9.2 B. Braun Melsungen AG
9.3 Baxter International Inc.
9.4 Becton, Dickinson and Company
9.5 DaVita Inc.
9.6 Fresenius Medical Care AG & Co.
9.7 Innovative Renal Care.
9.8 Medtronic plc
9.9 Nikkiso Co., Ltd.
9.10 Nipro Corporation
9.11 Northwest Kidney Centers
9.12 Sanderling Renal Services
9.13 Satellite Healthcare
9.14 Toray Industries Inc.
9.15 U.S. Renal Care, Inc.
CHAPTER 1 METHODOLOGY & SCOPE
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising number of end - stage renal diseases (ESRD) patients
3.2.1.2 Increasing incidence of diabetes
3.2.1.3 Shortage of donor kidneys
3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
3.2.1.5 Growing R&D investments
3.2.2 Industry pitfalls & challenges
3.2.2.1 Product recalls
3.2.2.2 Complications in the treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Value chain analysis
3.7 Future market trends
3.8 Technology landscape
3.9 Porter’s analysis
3.10 PESTEL analysis
CHAPTER 4 COMPETITIVE LANDSCAPE, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY TYPE, 2021 – 2032 ($ MN)
5.1 Key trends
5.2 Hemodialysis
5.3 Peritoneal dialysis
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY PRODUCT AND SERVICES, 2021 – 2032 ($ MN)
6.1 Key trends
6.2 Services
6.2.1 Chronic dialysis
6.2.2 Acute dialysis
6.3 Consumables
6.3.1 Dialyzers
6.3.2 Catheters
6.3.3 Access products
6.3.4 Concentrates
6.3.5 Other consumables
6.4 Equipment
6.4.1 Dialysis machines
6.4.2 Water treatment systems
6.4.3 Other equipment
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY END-USE, 2021 – 2032 ($ MN)
7.1 Key trends
7.2 In-center dialysis
7.3 Home dialysis
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY ZONE, 2021 – 2032 ($ MN)
8.1 Key trends
8.2 East North Central
8.3 West South Central
8.4 South Atlantic
8.5 North East
8.6 East South Central
8.7 West North Central
8.8 Pacific Central
8.9 Mountain States
CHAPTER 9 COMPANY PROFILES
9.1 Asahi Kasei Corporation
9.2 B. Braun Melsungen AG
9.3 Baxter International Inc.
9.4 Becton, Dickinson and Company
9.5 DaVita Inc.
9.6 Fresenius Medical Care AG & Co.
9.7 Innovative Renal Care.
9.8 Medtronic plc
9.9 Nikkiso Co., Ltd.
9.10 Nipro Corporation
9.11 Northwest Kidney Centers
9.12 Sanderling Renal Services
9.13 Satellite Healthcare
9.14 Toray Industries Inc.
9.15 U.S. Renal Care, Inc.
